Molecular Weight:   | 420.16 |
Volume:   | 433.107 |
LogP:   | 5.973 |
LogD:   | 4.02 |
LogS:   | -2.713 |
# Rotatable Bonds:   | 3 |
TPSA:   | 100.13 |
# H-Bond Aceptor:   | 6 |
# H-Bond Donor:   | 3 |
# Rings:   | 4 |
# Heavy Atoms:   | 6 |
QED Drug-Likeness Score:   | 0.499 |
Synthetic Accessibility Score:   | 3.284 |
Fsp3:   | 0.24 |
Lipinski Rule-of-5:   | Accepted |
Pfizer Rule:   | Accepted |
GSK Rule:   | Rejected |
BMS Rule:   | 0 |
Golden Triangle Rule:   | Accepted |
Chelating Alert:   | 0 |
PAINS Alert:   | 0 |
Caco-2 Permeability:   | -4.874 |
MDCK Permeability:   | 1.5354929928435013e-05 |
Pgp-inhibitor:   | 0.249 |
Pgp-substrate:   | 0.006 |
Human Intestinal Absorption (HIA):   | 0.051 |
20% Bioavailability (F20%):   | 0.027 |
30% Bioavailability (F30%):   | 0.223 |
Blood-Brain-Barrier Penetration (BBB):   | 0.009 |
Plasma Protein Binding (PPB):   | 97.67343139648438% |
Volume Distribution (VD):   | 0.564 |
Pgp-substrate:   | 3.7040040493011475% |
CYP1A2-inhibitor:   | 0.858 |
CYP1A2-substrate:   | 0.189 |
CYP2C19-inhibitor:   | 0.906 |
CYP2C19-substrate:   | 0.058 |
CYP2C9-inhibitor:   | 0.882 |
CYP2C9-substrate:   | 0.94 |
CYP2D6-inhibitor:   | 0.896 |
CYP2D6-substrate:   | 0.271 |
CYP3A4-inhibitor:   | 0.516 |
CYP3A4-substrate:   | 0.105 |
Clearance (CL):   | 4.881 |
Half-life (T1/2):   | 0.31 |
hERG Blockers:   | 0.026 |
Human Hepatotoxicity (H-HT):   | 0.952 |
Drug-inuced Liver Injury (DILI):   | 0.981 |
AMES Toxicity:   | 0.645 |
Rat Oral Acute Toxicity:   | 0.519 |
Maximum Recommended Daily Dose:   | 0.861 |
Skin Sensitization:   | 0.419 |
Carcinogencity:   | 0.855 |
Eye Corrosion:   | 0.003 |
Eye Irritation:   | 0.287 |
Respiratory Toxicity:   | 0.554 |
Natural Product ID:   | NPC62840 |
Common Name*:   | Morusin |
IUPAC Name:   | 2-(2,4-dihydroxyphenyl)-5-hydroxy-8,8-dimethyl-3-(3-methylbut-2-enyl)pyrano[2,3-h]chromen-4-one |
Synonyms:   | TCMDC-124149 |
Standard InCHIKey:   | XFFOMNJIDRDDLQ-UHFFFAOYSA-N |
Standard InCHI:   | InChI=1S/C25H24O6/c1-13(2)5-7-17-22(29)21-19(28)12-20-16(9-10-25(3,4)31-20)24(21)30-23(17)15-8-6-14(26)11-18(15)27/h5-6,8-12,26-28H,7H2,1-4H3 |
SMILES:   | CC(=CCc1c(oc2c(c1=O)c(O)cc1c2C=CC(O1)(C)C)c1ccc(cc1O)O)C |
Synthetic Gene Cluster:   | n.a. |
ChEMBL Identifier:   | CHEMBL464006 |
PubChem CID:   |
5281671 |
Chemical Classification**:   |
|
*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.
Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO11740 | Sagenomella striatispora | Species | Trichocomaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[10869218] |
NPO5495 | Broussonetia papyrifera | Species | Moraceae | Eukaryota | n.a. | root | n.a. |
PMID[11395279] |
NPO9402 | Morus mongolica | Species | Moraceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[11429996] |
NPO5495 | Broussonetia papyrifera | Species | Moraceae | Eukaryota | whole plants | Shawnee National Forest, Harrisburg, IL, US | n.a. |
PMID[11678652] |
NPO5495 | Broussonetia papyrifera | Species | Moraceae | Eukaryota | whole plants | n.a. | n.a. |
PMID[11678652] |
NPO10498 | Artocarpus dadah | Species | Moraceae | Eukaryota | bark and twigs | Tewah, Central Kalimantan, Indonesia (N 38 57.003; W 094 44.767) | 1999-Oct |
PMID[11858749] |
NPO5495 | Broussonetia papyrifera | Species | Moraceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[12419367] |
NPO11740 | Sagenomella striatispora | Species | Trichocomaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[15217294] |
NPO33150 | Artocarpus communis | Species | Moraceae | Eukaryota | heartwood | n.a. | n.a. |
PMID[16643064] |
NPO11796 | Morus australis | Species | Moraceae | Eukaryota | n.a. | root | n.a. |
PMID[17405024] |
NPO5495 | Broussonetia papyrifera | Species | Moraceae | Eukaryota | leaves | Kaohsiung, Taiwan | 2006-SEP |
PMID[18986201] |
NPO5495 | Broussonetia papyrifera | Species | Moraceae | Eukaryota | Fruits | n.a. | n.a. |
PMID[19296617] |
NPO28265 | Morus alba | Species | Moraceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[20815207] |
NPO28265 | Morus alba | Species | Moraceae | Eukaryota | n.a. | bark | n.a. |
PMID[21319773] |
NPO28265 | Morus alba | Species | Moraceae | Eukaryota | n.a. | root | n.a. |
PMID[21319773] |
NPO28265 | Morus alba | Species | Moraceae | Eukaryota | n.a. | leaf | n.a. |
PMID[21319773] |
NPO28265 | Morus alba | Species | Moraceae | Eukaryota | n.a. | leaf | n.a. |
PMID[22207282] |
NPO28265 | Morus alba | Species | Moraceae | Eukaryota | n.a. | root | n.a. |
PMID[23806866] |
NPO28265 | Morus alba | Species | Moraceae | Eukaryota | root bark | University of Veterinary and Pharmaceutical Sciences Brno (UVPS Brno), Brno, Czech Republic | 2011-APR |
PMID[24901948] |
NPO28265 | Morus alba | Species | Moraceae | Eukaryota | n.a. | Konya, Turkey | 2007-APR |
PMID[24901948] |
NPO33150 | Artocarpus communis | Species | Moraceae | Eukaryota | roots | Khon Kaen, Thailand | 2009-DEC |
PMID[25537111] |
NPO28265 | Morus alba | Species | Moraceae | Eukaryota | leaves | Chungbuk, Korea | n.a. |
PMID[25935644] |
NPO28265 | Morus alba | Species | Moraceae | Eukaryota | n.a. | root | n.a. |
PMID[25981820] |
NPO33150 | Artocarpus communis | Species | Moraceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[26178912] |
NPO9090 | Patrinia villosa | Species | Caprifoliaceae | Eukaryota | n.a. | leaf | n.a. |
PMID[27019553] |
NPO28265 | Morus alba | Species | Moraceae | Eukaryota | n.a. | latex | n.a. |
PMID[27294120] |
NPO11796 | Morus australis | Species | Moraceae | Eukaryota | Root Bark | n.a. | n.a. |
PMID[27908762] |
NPO12588 | Cornus officinalis | Species | Cornaceae | Eukaryota | Fruits | n.a. | n.a. |
PMID[29140705] |
NPO28265 | Morus alba | Species | Moraceae | Eukaryota | Root barks | n.a. | n.a. |
PMID[3097265] |
NPO5495 | Broussonetia papyrifera | Species | Moraceae | Eukaryota | n.a. | formosan | n.a. |
PMID[8864236] |
NPO11796 | Morus australis | Species | Moraceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[9358644] |
NPO5495 | Broussonetia papyrifera | Species | Moraceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[9358644] |
NPO9402 | Morus mongolica | Species | Moraceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO17949 | Gentiana thunbergii | Species | Gentianaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO10498 | Artocarpus dadah | Species | Moraceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO5495 | Broussonetia papyrifera | Species | Moraceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO12588 | Cornus officinalis | Species | Cornaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO31552 | Lonicera morrowii | Species | Caprifoliaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO26579 | Artocarpus fretessi | Species | Moraceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO28265 | Morus alba | Species | Moraceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO9090 | Patrinia villosa | Species | Caprifoliaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO11688 | Adoxa moschatellina | Species | Adoxaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO11796 | Morus australis | Species | Moraceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO11688 | Adoxa moschatellina | Species | Adoxaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO14802.1 | Lonicera tatarica var. morrowii | Varieties | Caprifoliaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO8352 | Canthium berberidifolium | Species | Rubiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO10498 | Artocarpus dadah | Species | Moraceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO5495 | Broussonetia papyrifera | Species | Moraceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO26579 | Artocarpus fretessi | Species | Moraceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO12588 | Cornus officinalis | Species | Cornaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO11796 | Morus australis | Species | Moraceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO28265 | Morus alba | Species | Moraceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO9090 | Patrinia villosa | Species | Caprifoliaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO9402 | Morus mongolica | Species | Moraceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO17949 | Gentiana thunbergii | Species | Gentianaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO9090 | Patrinia villosa | Species | Caprifoliaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO9402 | Morus mongolica | Species | Moraceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO28265 | Morus alba | Species | Moraceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO12588 | Cornus officinalis | Species | Cornaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO5495 | Broussonetia papyrifera | Species | Moraceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO12588 | Cornus officinalis | Species | Cornaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO9090 | Patrinia villosa | Species | Caprifoliaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO5495 | Broussonetia papyrifera | Species | Moraceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO28265 | Morus alba | Species | Moraceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO9402 | Morus mongolica | Species | Moraceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO12588 | Cornus officinalis | Species | Cornaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO5495 | Broussonetia papyrifera | Species | Moraceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO11688 | Adoxa moschatellina | Species | Adoxaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO17949 | Gentiana thunbergii | Species | Gentianaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO10498 | Artocarpus dadah | Species | Moraceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO14802.1 | Lonicera tatarica var. morrowii | Varieties | Caprifoliaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO8352 | Canthium berberidifolium | Species | Rubiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO28265 | Morus alba | Species | Moraceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO11796 | Morus australis | Species | Moraceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO9090 | Patrinia villosa | Species | Caprifoliaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO11740 | Sagenomella striatispora | Species | Trichocomaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Organism ID | NP ID | Organism Material Preparation | Organism Part | NP Quantity (Standard) | NP Quantity (Minimum) | NP Quantity (Maximum) | Quantity Unit | Reference |
---|
☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT31 | Individual Protein | Cyclooxygenase-2 | Homo sapiens | IC50 | = | 100000.0 | nM | PMID[482595] |
NPT30 | Individual Protein | Cyclooxygenase-1 | Homo sapiens | IC50 | = | 100000.0 | nM | PMID[482595] |
NPT65 | Cell Line | HepG2 | Homo sapiens | Inhibition | = | 1.0 | % | PMID[482597] |
NPT1254 | Individual Protein | Streptokinase A | Streptococcus pyogenes serotype M1 | EC50 | = | 1234.0 | nM | PMID[482598] |
NPT1254 | Individual Protein | Streptokinase A | Streptococcus pyogenes serotype M1 | EC50 | = | 1149.0 | nM | PMID[482598] |
NPT532 | Individual Protein | Lysine-specific demethylase 4A | Homo sapiens | Potency | n.a. | 44668.4 | nM | PMID[482598] |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | n.a. | 18356.4 | nM | PMID[482598] |
NPT31 | Individual Protein | Cyclooxygenase-2 | Homo sapiens | IC50 | = | 100000.0 | nM | PMID[482600] |
NPT324 | Individual Protein | Cyclooxygenase-1 | Ovis aries | IC50 | = | 100000.0 | nM | PMID[482600] |
NPT570 | Individual Protein | Arachidonate 5-lipoxygenase | Homo sapiens | IC50 | = | 100000.0 | nM | PMID[482600] |
NPT1119 | Individual Protein | Arachidonate 12-lipoxygenase | Homo sapiens | IC50 | = | 100000.0 | nM | PMID[482600] |
NPT65 | Cell Line | HepG2 | Homo sapiens | Potency | n.a. | 17782.8 | nM | PMID[482598] |
NPT154 | Individual Protein | Mothers against decapentaplegic homolog 3 | Homo sapiens | Potency | n.a. | 22387.2 | nM | PMID[482598] |
NPT478 | Individual Protein | Ataxin-2 | Homo sapiens | Potency | n.a. | 26679.5 | nM | PMID[482598] |
NPT101 | Individual Protein | Glucagon-like peptide 1 receptor | Homo sapiens | Potency | n.a. | 6309.6 | nM | PMID[482598] |
NPT11 | Individual Protein | Guanine nucleotide-binding protein G(s), subunit alpha | Homo sapiens | Potency | n.a. | 8912.5 | nM | PMID[482598] |
NPT439 | Individual Protein | Butyrylcholinesterase | Homo sapiens | IC50 | = | 1700.0 | nM | PMID[482601] |
NPT204 | Individual Protein | Acetylcholinesterase | Homo sapiens | Ki | = | 3100.0 | nM | PMID[482601] |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | n.a. | 20596.2 | nM | PMID[482598] |
NPT160 | Individual Protein | TAR DNA-binding protein 43 | Homo sapiens | Potency | n.a. | 35481.3 | nM | PMID[482598] |
NPT535 | Individual Protein | Parathyroid hormone receptor | Homo sapiens | Potency | n.a. | 22387.2 | nM | PMID[482598] |
NPT446 | Individual Protein | Rap guanine nucleotide exchange factor 3 | Homo sapiens | Potency | n.a. | 56234.1 | nM | PMID[482598] |
NPT196 | Cell Line | AGS | Homo sapiens | Activity | = | 25.0 | % | PMID[482602] |
NPT1125 | Cell Line | T98G | Homo sapiens | CI | < | 0.8 | n.a. | PMID[482604] |
NPT1125 | Cell Line | T98G | Homo sapiens | IC50 | = | 24000.0 | nM | PMID[482604] |
NPT113 | Cell Line | RAW264.7 | Mus musculus | Inhibition | = | 15.1 | % | PMID[482605] |
NPT113 | Cell Line | RAW264.7 | Mus musculus | Inhibition | = | 23.3 | % | PMID[482605] |
NPT113 | Cell Line | RAW264.7 | Mus musculus | Inhibition | = | 39.3 | % | PMID[482605] |
NPT113 | Cell Line | RAW264.7 | Mus musculus | IC50 | > | 12.5 | ug.mL-1 | PMID[482605] |
NPT1464 | Individual Protein | Phosphodiesterase 4D | Homo sapiens | IC50 | = | 900.0 | nM | PMID[482606] |
NPT3997 | Individual Protein | Hematopoietic cell protein-tyrosine phosphatase 70Z-PEP | Homo sapiens | IC50 | = | 14970.0 | nM | PMID[482608] |
NPT178 | Individual Protein | Protein-tyrosine phosphatase 1B | Homo sapiens | IC50 | = | 10320.0 | nM | PMID[482608] |
NPT3985 | Individual Protein | Probable low molecular weight protein-tyrosine-phosphatase | Mycobacterium tuberculosis | IC50 | = | 4650.0 | nM | PMID[482608] |
NPT1872 | Cell Line | Bcap37 | Homo sapiens | IC50 | = | 33100.0 | nM | PMID[482609] |
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | = | 11510.0 | nM | PMID[482609] |
NPT65 | Cell Line | HepG2 | Homo sapiens | IC50 | = | 9300.0 | nM | PMID[482609] |
NPT81 | Cell Line | A549 | Homo sapiens | IC50 | = | 24090.0 | nM | PMID[482609] |
NPT380 | Cell Line | U-251 | Homo sapiens | IC50 | = | 17950.0 | nM | PMID[482609] |
NPT5536 | Individual Protein | Sarcoplasmic/endoplasmic reticulum calcium ATP-ase | Oryctolagus cuniculus | IC50 | = | 43570.0 | nM | PMID[482610] |
NPT6571 | Individual Protein | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | Rattus norvegicus | IC50 | = | 28650.0 | nM | PMID[482610] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | Activity | = | 81.8 | % | PMID[482596] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | Activity | = | 0.0 | % | PMID[482596] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | Activity | = | 74.2 | % | PMID[482596] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | Activity | = | 82.8 | % | PMID[482596] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | Activity | = | 5.3 | % | PMID[482596] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | Activity | = | 62.5 | % | PMID[482596] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | Activity | = | 81.3 | % | PMID[482596] |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | XC50 | = | 977.3 | nM | PMID[482597] |
NPT2 | Others | Unspecified | IFI | = | 9.09 | % | PMID[482597] | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Inhibition | = | 8.0 | % | PMID[482597] |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Inhibition | = | 89.0 | % | PMID[482597] |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Inhibition | = | 5.0 | % | PMID[482597] |
NPT174 | Organism | Streptococcus | Streptococcus | EC50 | = | 2965.0 | nM | PMID[482598] |
NPT1252 | Organism | Streptococcus sp. 'group A' | Streptococcus sp. 'group A' | EC50 | = | 2715.0 | nM | PMID[482598] |
NPT740 | Individual Protein | Beta-secretase 1 | Homo sapiens | Ki | = | 64100.0 | nM | PMID[482599] |
NPT740 | Individual Protein | Beta-secretase 1 | Homo sapiens | IC50 | = | 59400.0 | nM | PMID[482599] |
NPT803 | Individual Protein | Flap endonuclease 1 | Homo sapiens | Potency | n.a. | 31622.8 | nM | PMID[482598] |
NPT2 | Others | Unspecified | Potency | n.a. | 15848.9 | nM | PMID[482598] | |
NPT2 | Others | Unspecified | Potency | n.a. | 14125.4 | nM | PMID[482598] | |
NPT755 | Individual Protein | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens | Potency | n.a. | 79432.8 | nM | PMID[482598] |
NPT861 | Individual Protein | Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens | Potency | n.a. | 29092.9 | nM | PMID[482598] |
NPT920 | Individual Protein | Alpha-synuclein | Homo sapiens | Potency | n.a. | 17782.8 | nM | PMID[482598] |
NPT942 | Individual Protein | Glucose transporter | Homo sapiens | Inhibition | = | 5.72 | % | PMID[482603] |
NPT943 | Individual Protein | Hexose transporter 1 | Plasmodium falciparum | Inhibition | = | 4.6 | % | PMID[482603] |
NPT944 | Individual Protein | Glucose transporter | Leishmania mexicana | Inhibition | = | 6.57 | % | PMID[482603] |
NPT2 | Others | Unspecified | Potency | n.a. | 39810.7 | nM | PMID[482598] | |
NPT27 | Others | Unspecified | Stability | > | 94.0 | % | PMID[482604] | |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | IC50 | = | 24000.0 | nM | PMID[482604] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | CI | < | 0.8 | n.a. | PMID[482604] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | Activity | = | 29.0 | % | PMID[482604] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | Activity | = | 10.0 | % | PMID[482604] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | Activity | = | 60.22 | % | PMID[482605] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | Activity | < | 60.0 | % | PMID[482605] |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 94.5 | % | PMID[482605] |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 83.3 | % | PMID[482605] |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 73.8 | % | PMID[482605] |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 69.6 | % | PMID[482605] |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 23.1 | % | PMID[482605] |
NPT21334 | CELL-LINE | MC3T3-E1 | Mus musculus | Activity | = | 16.01 | % | PMID[482607] |
NPT21334 | CELL-LINE | MC3T3-E1 | Mus musculus | Activity | = | 9.57 | % | PMID[482607] |
NPT21334 | CELL-LINE | MC3T3-E1 | Mus musculus | Activity | = | 3.88 | % | PMID[482607] |
NPT21334 | CELL-LINE | MC3T3-E1 | Mus musculus | Activity | = | 7.13 | % | PMID[482607] |
NPT22768 | SINGLE PROTEIN | Phosphotyrosine protein phosphatase | Mycobacterium tuberculosis | IC50 | = | 5248.07 | nM | PMID[482608] |
NPT2 | Others | Unspecified | Ratio IC50 | > | 19.0 | n.a. | PMID[482608] | |
NPT24759 | SINGLE PROTEIN | Protein-tyrosine phosphatase G1 | Homo sapiens | IC50 | > | 100000.0 | nM | PMID[482608] |
NPT2 | Others | Unspecified | Ratio IC50 | = | 2.8 | n.a. | PMID[482608] | |
NPT2 | Others | Unspecified | Ratio IC50 | = | 2.0 | n.a. | PMID[482608] | |
NPT2 | Others | Unspecified | Ratio IC50 | = | 0.9 | n.a. | PMID[482608] | |
NPT22768 | SINGLE PROTEIN | Phosphotyrosine protein phosphatase | Mycobacterium tuberculosis | IC50 | = | 5260.0 | nM | PMID[482608] |
☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.
Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC62840 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC299080 |
1.0 | High Similarity | NPC59739 |
1.0 | High Similarity | NPC293852 |
1.0 | High Similarity | NPC214236 |
1.0 | High Similarity | NPC217083 |
1.0 | High Similarity | NPC78803 |
0.9783 | High Similarity | NPC38219 |
0.9783 | High Similarity | NPC219915 |
0.9781 | High Similarity | NPC156590 |
0.9781 | High Similarity | NPC205006 |
0.9781 | High Similarity | NPC118840 |
0.9781 | High Similarity | NPC64908 |
0.9781 | High Similarity | NPC147688 |
0.9779 | High Similarity | NPC220062 |
0.9779 | High Similarity | NPC96565 |
0.9779 | High Similarity | NPC301217 |
0.9779 | High Similarity | NPC303633 |
0.9779 | High Similarity | NPC216978 |
0.9779 | High Similarity | NPC55018 |
0.9714 | High Similarity | NPC166757 |
0.9714 | High Similarity | NPC97716 |
0.9714 | High Similarity | NPC237635 |
0.9714 | High Similarity | NPC104406 |
0.9714 | High Similarity | NPC201731 |
0.9714 | High Similarity | NPC14001 |
0.9714 | High Similarity | NPC24673 |
0.9714 | High Similarity | NPC79469 |
0.9712 | High Similarity | NPC319752 |
0.971 | High Similarity | NPC11561 |
0.971 | High Similarity | NPC226636 |
0.9708 | High Similarity | NPC172986 |
0.9708 | High Similarity | NPC159275 |
0.9708 | High Similarity | NPC241100 |
0.9708 | High Similarity | NPC270883 |
0.9708 | High Similarity | NPC305355 |
0.9708 | High Similarity | NPC261227 |
0.9708 | High Similarity | NPC475680 |
0.9708 | High Similarity | NPC150522 |
0.9708 | High Similarity | NPC235239 |
0.9706 | High Similarity | NPC201395 |
0.9645 | High Similarity | NPC244407 |
0.9645 | High Similarity | NPC266572 |
0.9645 | High Similarity | NPC189087 |
0.9645 | High Similarity | NPC321623 |
0.9645 | High Similarity | NPC161191 |
0.9645 | High Similarity | NPC6511 |
0.9643 | High Similarity | NPC20488 |
0.9643 | High Similarity | NPC176229 |
0.9643 | High Similarity | NPC111786 |
0.9643 | High Similarity | NPC474161 |
0.9643 | High Similarity | NPC312973 |
0.9643 | High Similarity | NPC220418 |
0.9643 | High Similarity | NPC470647 |
0.9643 | High Similarity | NPC301276 |
0.9643 | High Similarity | NPC246948 |
0.9643 | High Similarity | NPC54577 |
0.9643 | High Similarity | NPC475052 |
0.9643 | High Similarity | NPC88964 |
0.9643 | High Similarity | NPC476088 |
0.9643 | High Similarity | NPC57470 |
0.9643 | High Similarity | NPC267375 |
0.9643 | High Similarity | NPC195621 |
0.9643 | High Similarity | NPC142405 |
0.9643 | High Similarity | NPC67805 |
0.9643 | High Similarity | NPC83357 |
0.9643 | High Similarity | NPC214774 |
0.9638 | High Similarity | NPC110969 |
0.9638 | High Similarity | NPC14871 |
0.9638 | High Similarity | NPC103362 |
0.9638 | High Similarity | NPC282300 |
0.9635 | High Similarity | NPC18260 |
0.9635 | High Similarity | NPC78913 |
0.9635 | High Similarity | NPC217186 |
0.9635 | High Similarity | NPC53181 |
0.9577 | High Similarity | NPC5173 |
0.9574 | High Similarity | NPC296998 |
0.9574 | High Similarity | NPC180477 |
0.9574 | High Similarity | NPC473077 |
0.9574 | High Similarity | NPC297886 |
0.9574 | High Similarity | NPC23728 |
0.9574 | High Similarity | NPC283234 |
0.9574 | High Similarity | NPC110303 |
0.9574 | High Similarity | NPC249942 |
0.9571 | High Similarity | NPC257236 |
0.9571 | High Similarity | NPC278175 |
0.9571 | High Similarity | NPC234629 |
0.9571 | High Similarity | NPC311741 |
0.9568 | High Similarity | NPC200694 |
0.9568 | High Similarity | NPC144499 |
0.9565 | High Similarity | NPC69769 |
0.9562 | High Similarity | NPC470668 |
0.9562 | High Similarity | NPC470669 |
0.9562 | High Similarity | NPC17848 |
0.9559 | High Similarity | NPC13408 |
0.951 | High Similarity | NPC471984 |
0.951 | High Similarity | NPC188403 |
0.9507 | High Similarity | NPC132592 |
0.9507 | High Similarity | NPC296869 |
0.9507 | High Similarity | NPC161864 |
0.9507 | High Similarity | NPC469933 |
0.9507 | High Similarity | NPC208303 |
0.9507 | High Similarity | NPC160821 |
0.9504 | High Similarity | NPC124729 |
0.9504 | High Similarity | NPC329678 |
0.95 | High Similarity | NPC190637 |
0.95 | High Similarity | NPC478086 |
0.95 | High Similarity | NPC212932 |
0.95 | High Similarity | NPC18585 |
0.95 | High Similarity | NPC166138 |
0.95 | High Similarity | NPC106985 |
0.95 | High Similarity | NPC9117 |
0.95 | High Similarity | NPC293053 |
0.95 | High Similarity | NPC11700 |
0.95 | High Similarity | NPC24821 |
0.95 | High Similarity | NPC316816 |
0.95 | High Similarity | NPC214166 |
0.9493 | High Similarity | NPC23257 |
0.9489 | High Similarity | NPC157855 |
0.9441 | High Similarity | NPC469932 |
0.9437 | High Similarity | NPC140120 |
0.9433 | High Similarity | NPC131568 |
0.9433 | High Similarity | NPC326500 |
0.9433 | High Similarity | NPC209040 |
0.9433 | High Similarity | NPC216538 |
0.9433 | High Similarity | NPC469953 |
0.9433 | High Similarity | NPC131579 |
0.9433 | High Similarity | NPC273538 |
0.9429 | High Similarity | NPC148757 |
0.9429 | High Similarity | NPC76372 |
0.9429 | High Similarity | NPC32739 |
0.9429 | High Similarity | NPC66515 |
0.9429 | High Similarity | NPC473042 |
0.9429 | High Similarity | NPC166482 |
0.9429 | High Similarity | NPC107572 |
0.9429 | High Similarity | NPC324134 |
0.9429 | High Similarity | NPC161506 |
0.9429 | High Similarity | NPC36181 |
0.9429 | High Similarity | NPC324436 |
0.9429 | High Similarity | NPC194432 |
0.9429 | High Similarity | NPC167624 |
0.9429 | High Similarity | NPC37496 |
0.9429 | High Similarity | NPC166934 |
0.9429 | High Similarity | NPC220998 |
0.9429 | High Similarity | NPC76338 |
0.9429 | High Similarity | NPC227579 |
0.9429 | High Similarity | NPC228504 |
0.9429 | High Similarity | NPC78 |
0.9429 | High Similarity | NPC10937 |
0.9429 | High Similarity | NPC223500 |
0.9429 | High Similarity | NPC328164 |
0.9429 | High Similarity | NPC177354 |
0.9429 | High Similarity | NPC64915 |
0.9429 | High Similarity | NPC265040 |
0.9429 | High Similarity | NPC40833 |
0.9429 | High Similarity | NPC125855 |
0.9429 | High Similarity | NPC182852 |
0.9429 | High Similarity | NPC296917 |
0.9429 | High Similarity | NPC1089 |
0.9429 | High Similarity | NPC306829 |
0.9424 | High Similarity | NPC471587 |
0.942 | High Similarity | NPC248995 |
0.942 | High Similarity | NPC272844 |
0.942 | High Similarity | NPC131130 |
0.942 | High Similarity | NPC254168 |
0.9416 | High Similarity | NPC29353 |
0.9416 | High Similarity | NPC124784 |
0.9416 | High Similarity | NPC127447 |
0.9416 | High Similarity | NPC161196 |
0.9416 | High Similarity | NPC231772 |
0.9416 | High Similarity | NPC473887 |
0.9416 | High Similarity | NPC194281 |
0.9416 | High Similarity | NPC234133 |
0.9416 | High Similarity | NPC174999 |
0.9416 | High Similarity | NPC47815 |
0.9379 | High Similarity | NPC45934 |
0.9375 | High Similarity | NPC471115 |
0.9375 | High Similarity | NPC472633 |
0.9375 | High Similarity | NPC29777 |
0.9375 | High Similarity | NPC151973 |
0.9366 | High Similarity | NPC5820 |
0.9366 | High Similarity | NPC285630 |
0.9366 | High Similarity | NPC154217 |
0.9366 | High Similarity | NPC127059 |
0.9366 | High Similarity | NPC470131 |
0.9366 | High Similarity | NPC470134 |
0.9366 | High Similarity | NPC178343 |
0.9366 | High Similarity | NPC477955 |
0.9366 | High Similarity | NPC473078 |
0.9366 | High Similarity | NPC470133 |
0.9366 | High Similarity | NPC109183 |
0.9366 | High Similarity | NPC470132 |
0.9366 | High Similarity | NPC306488 |
0.9362 | High Similarity | NPC81697 |
0.9362 | High Similarity | NPC188632 |
0.9362 | High Similarity | NPC185276 |
0.9362 | High Similarity | NPC91560 |
0.9362 | High Similarity | NPC149026 |
0.9362 | High Similarity | NPC75049 |
0.9362 | High Similarity | NPC107177 |
0.9362 | High Similarity | NPC143896 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC62840 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9571 | High Similarity | NPD7410 | Clinical (unspecified phase) |
0.9433 | High Similarity | NPD4378 | Clinical (unspecified phase) |
0.9071 | High Similarity | NPD1550 | Clinical (unspecified phase) |
0.9071 | High Similarity | NPD1552 | Clinical (unspecified phase) |
0.9007 | High Similarity | NPD1549 | Phase 2 |
0.8929 | High Similarity | NPD1510 | Phase 2 |
0.8919 | High Similarity | NPD7411 | Suspended |
0.8913 | High Similarity | NPD1240 | Approved |
0.8867 | High Similarity | NPD8443 | Clinical (unspecified phase) |
0.8865 | High Similarity | NPD2796 | Approved |
0.8851 | High Similarity | NPD4380 | Phase 2 |
0.88 | High Similarity | NPD2393 | Clinical (unspecified phase) |
0.8786 | High Similarity | NPD1607 | Approved |
0.8699 | High Similarity | NPD1511 | Approved |
0.8627 | High Similarity | NPD7075 | Discontinued |
0.8621 | High Similarity | NPD3750 | Approved |
0.8609 | High Similarity | NPD6801 | Discontinued |
0.8581 | High Similarity | NPD1512 | Approved |
0.8553 | High Similarity | NPD7819 | Suspended |
0.8553 | High Similarity | NPD7096 | Clinical (unspecified phase) |
0.8553 | High Similarity | NPD2801 | Approved |
0.8506 | High Similarity | NPD4381 | Clinical (unspecified phase) |
0.8487 | Intermediate Similarity | NPD1934 | Approved |
0.8446 | Intermediate Similarity | NPD6799 | Approved |
0.8442 | Intermediate Similarity | NPD7768 | Phase 2 |
0.8425 | Intermediate Similarity | NPD2800 | Approved |
0.8425 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.8418 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.8387 | Intermediate Similarity | NPD3749 | Approved |
0.8375 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.8344 | Intermediate Similarity | NPD6959 | Discontinued |
0.8299 | Intermediate Similarity | NPD1243 | Approved |
0.8278 | Intermediate Similarity | NPD5403 | Approved |
0.8276 | Intermediate Similarity | NPD3748 | Approved |
0.8264 | Intermediate Similarity | NPD6651 | Approved |
0.8239 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.8235 | Intermediate Similarity | NPD6599 | Discontinued |
0.8231 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.8205 | Intermediate Similarity | NPD3882 | Suspended |
0.8187 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.8187 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.8187 | Intermediate Similarity | NPD6166 | Phase 2 |
0.8151 | Intermediate Similarity | NPD2799 | Discontinued |
0.8146 | Intermediate Similarity | NPD5401 | Approved |
0.8141 | Intermediate Similarity | NPD3817 | Phase 2 |
0.8112 | Intermediate Similarity | NPD2313 | Discontinued |
0.8095 | Intermediate Similarity | NPD2935 | Discontinued |
0.8095 | Intermediate Similarity | NPD1551 | Phase 2 |
0.8061 | Intermediate Similarity | NPD4419 | Clinical (unspecified phase) |
0.805 | Intermediate Similarity | NPD5494 | Approved |
0.8041 | Intermediate Similarity | NPD2344 | Approved |
0.8039 | Intermediate Similarity | NPD920 | Approved |
0.8037 | Intermediate Similarity | NPD7054 | Approved |
0.8014 | Intermediate Similarity | NPD1203 | Approved |
0.8013 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.7988 | Intermediate Similarity | NPD7472 | Approved |
0.7988 | Intermediate Similarity | NPD7074 | Phase 3 |
0.7986 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.7986 | Intermediate Similarity | NPD3268 | Approved |
0.7975 | Intermediate Similarity | NPD3818 | Discontinued |
0.7973 | Intermediate Similarity | NPD6099 | Approved |
0.7973 | Intermediate Similarity | NPD6100 | Approved |
0.795 | Intermediate Similarity | NPD6232 | Discontinued |
0.7945 | Intermediate Similarity | NPD5124 | Phase 1 |
0.7945 | Intermediate Similarity | NPD5123 | Clinical (unspecified phase) |
0.7943 | Intermediate Similarity | NPD3225 | Approved |
0.7939 | Intermediate Similarity | NPD5953 | Discontinued |
0.7939 | Intermediate Similarity | NPD6797 | Phase 2 |
0.7927 | Intermediate Similarity | NPD7286 | Phase 2 |
0.7914 | Intermediate Similarity | NPD7473 | Discontinued |
0.7911 | Intermediate Similarity | NPD5402 | Approved |
0.7908 | Intermediate Similarity | NPD2532 | Approved |
0.7908 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.7908 | Intermediate Similarity | NPD2534 | Approved |
0.7908 | Intermediate Similarity | NPD2533 | Approved |
0.7905 | Intermediate Similarity | NPD7033 | Discontinued |
0.7905 | Intermediate Similarity | NPD1509 | Clinical (unspecified phase) |
0.7892 | Intermediate Similarity | NPD7251 | Discontinued |
0.7887 | Intermediate Similarity | NPD2797 | Approved |
0.7881 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.7862 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.7857 | Intermediate Similarity | NPD422 | Phase 1 |
0.7847 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7844 | Intermediate Similarity | NPD7808 | Phase 3 |
0.7843 | Intermediate Similarity | NPD7390 | Discontinued |
0.7832 | Intermediate Similarity | NPD2798 | Approved |
0.7829 | Intermediate Similarity | NPD2309 | Approved |
0.7826 | Intermediate Similarity | NPD1548 | Phase 1 |
0.7821 | Intermediate Similarity | NPD3226 | Approved |
0.7801 | Intermediate Similarity | NPD9717 | Approved |
0.7785 | Intermediate Similarity | NPD4308 | Phase 3 |
0.7784 | Intermediate Similarity | NPD6559 | Discontinued |
0.7763 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7755 | Intermediate Similarity | NPD943 | Approved |
0.7738 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.773 | Intermediate Similarity | NPD1547 | Clinical (unspecified phase) |
0.7724 | Intermediate Similarity | NPD6832 | Phase 2 |
0.7711 | Intermediate Similarity | NPD5844 | Phase 1 |
0.7701 | Intermediate Similarity | NPD4363 | Phase 3 |
0.7701 | Intermediate Similarity | NPD4360 | Phase 2 |
0.7682 | Intermediate Similarity | NPD2346 | Discontinued |
0.7671 | Intermediate Similarity | NPD4625 | Phase 3 |
0.7654 | Intermediate Similarity | NPD919 | Approved |
0.7647 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7639 | Intermediate Similarity | NPD3267 | Approved |
0.7639 | Intermediate Similarity | NPD3266 | Approved |
0.7614 | Intermediate Similarity | NPD8090 | Clinical (unspecified phase) |
0.7606 | Intermediate Similarity | NPD1610 | Phase 2 |
0.7582 | Intermediate Similarity | NPD2654 | Approved |
0.7578 | Intermediate Similarity | NPD4288 | Approved |
0.7561 | Intermediate Similarity | NPD1247 | Approved |
0.7557 | Intermediate Similarity | NPD4362 | Clinical (unspecified phase) |
0.7557 | Intermediate Similarity | NPD4361 | Phase 2 |
0.7547 | Intermediate Similarity | NPD6585 | Discontinued |
0.7517 | Intermediate Similarity | NPD4307 | Phase 2 |
0.7516 | Intermediate Similarity | NPD1465 | Phase 2 |
0.75 | Intermediate Similarity | NPD1296 | Phase 2 |
0.75 | Intermediate Similarity | NPD7615 | Clinical (unspecified phase) |
0.747 | Intermediate Similarity | NPD3926 | Phase 2 |
0.7456 | Intermediate Similarity | NPD1729 | Discontinued |
0.7431 | Intermediate Similarity | NPD1608 | Approved |
0.7431 | Intermediate Similarity | NPD3972 | Approved |
0.7412 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.7391 | Intermediate Similarity | NPD5890 | Approved |
0.7391 | Intermediate Similarity | NPD5889 | Approved |
0.7386 | Intermediate Similarity | NPD5406 | Approved |
0.7386 | Intermediate Similarity | NPD5405 | Approved |
0.7386 | Intermediate Similarity | NPD5404 | Approved |
0.7386 | Intermediate Similarity | NPD5408 | Approved |
0.7383 | Intermediate Similarity | NPD3764 | Approved |
0.7379 | Intermediate Similarity | NPD4749 | Approved |
0.7375 | Intermediate Similarity | NPD7458 | Discontinued |
0.7371 | Intermediate Similarity | NPD4287 | Approved |
0.7365 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.7361 | Intermediate Similarity | NPD1201 | Approved |
0.7358 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7351 | Intermediate Similarity | NPD1933 | Approved |
0.7342 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7337 | Intermediate Similarity | NPD7584 | Approved |
0.7337 | Intermediate Similarity | NPD5940 | Clinical (unspecified phase) |
0.7324 | Intermediate Similarity | NPD9545 | Approved |
0.7321 | Intermediate Similarity | NPD7784 | Clinical (unspecified phase) |
0.7308 | Intermediate Similarity | NPD7003 | Approved |
0.7305 | Intermediate Similarity | NPD5710 | Approved |
0.7305 | Intermediate Similarity | NPD9493 | Approved |
0.7305 | Intermediate Similarity | NPD5711 | Approved |
0.7297 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.7296 | Intermediate Similarity | NPD5049 | Phase 3 |
0.7288 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.7279 | Intermediate Similarity | NPD1470 | Approved |
0.7279 | Intermediate Similarity | NPD1164 | Approved |
0.7267 | Intermediate Similarity | NPD411 | Approved |
0.7267 | Intermediate Similarity | NPD6798 | Discontinued |
0.7267 | Intermediate Similarity | NPD5808 | Clinical (unspecified phase) |
0.7261 | Intermediate Similarity | NPD2354 | Approved |
0.7256 | Intermediate Similarity | NPD2296 | Approved |
0.7237 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.7237 | Intermediate Similarity | NPD447 | Suspended |
0.7226 | Intermediate Similarity | NPD1471 | Phase 3 |
0.7222 | Intermediate Similarity | NPD17 | Approved |
0.7214 | Intermediate Similarity | NPD1241 | Discontinued |
0.7202 | Intermediate Similarity | NPD7229 | Phase 3 |
0.7198 | Intermediate Similarity | NPD7501 | Clinical (unspecified phase) |
0.7192 | Intermediate Similarity | NPD1481 | Phase 2 |
0.7171 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7171 | Intermediate Similarity | NPD1613 | Approved |
0.717 | Intermediate Similarity | NPD7212 | Phase 2 |
0.717 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.717 | Intermediate Similarity | NPD7213 | Phase 3 |
0.7168 | Intermediate Similarity | NPD6104 | Discontinued |
0.7153 | Intermediate Similarity | NPD4196 | Clinical (unspecified phase) |
0.7152 | Intermediate Similarity | NPD6410 | Clinical (unspecified phase) |
0.7135 | Intermediate Similarity | NPD3751 | Discontinued |
0.7134 | Intermediate Similarity | NPD7577 | Discontinued |
0.7134 | Intermediate Similarity | NPD6844 | Discontinued |
0.7133 | Intermediate Similarity | NPD1008 | Clinical (unspecified phase) |
0.7125 | Intermediate Similarity | NPD7447 | Phase 1 |
0.7124 | Intermediate Similarity | NPD230 | Phase 1 |
0.7123 | Intermediate Similarity | NPD1535 | Discovery |
0.7118 | Intermediate Similarity | NPD2403 | Approved |
0.7115 | Intermediate Similarity | NPD2355 | Clinical (unspecified phase) |
0.7115 | Intermediate Similarity | NPD2353 | Approved |
0.7115 | Intermediate Similarity | NPD2343 | Clinical (unspecified phase) |
0.7114 | Intermediate Similarity | NPD1019 | Discontinued |
0.7101 | Intermediate Similarity | NPD3787 | Discontinued |
0.7097 | Intermediate Similarity | NPD651 | Clinical (unspecified phase) |
0.7086 | Intermediate Similarity | NPD8312 | Approved |
0.7086 | Intermediate Similarity | NPD8313 | Approved |
0.707 | Intermediate Similarity | NPD2424 | Discontinued |
0.7051 | Intermediate Similarity | NPD4476 | Approved |
0.7051 | Intermediate Similarity | NPD4477 | Approved |
0.7044 | Intermediate Similarity | NPD3887 | Approved |
0.7044 | Intermediate Similarity | NPD3295 | Clinical (unspecified phase) |
0.7041 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7035 | Intermediate Similarity | NPD7177 | Discontinued |
0.7035 | Intermediate Similarity | NPD7893 | Clinical (unspecified phase) |
0.7025 | Intermediate Similarity | NPD1652 | Phase 2 |
0.7021 | Intermediate Similarity | NPD5535 | Approved |
0.7019 | Intermediate Similarity | NPD4662 | Approved |
0.7019 | Intermediate Similarity | NPD4661 | Approved |
Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
☉ A: chemistry similarity;
☉ B: biological targets similarity;
☉ C: networks similarity;
☉ D: cell-based bioactivity similarity;
☉ E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.